Anacor Pharmaceuticals to Present at the ordinal Annual Bio Investor Forum MarketWatch (press release) In addition, Anacor is nonindustrial AN2718 as a topical antifungal product candidate for the treatment of onychomycosis and skin fungal infections, and AN2898 as type A topical anti-inflammatory product nominee for the treatment of psoriasis and atopic ... and more » Link To Article
No comments:
Post a Comment